Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Acquires 18,411 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 18,411 shares of Retractable Technologies stock in a transaction that occurred on Monday, January 6th. The stock was acquired at an average cost of $0.78 per share, with a total value of $14,360.58. Following the transaction, the chief executive officer now owns 14,947,978 shares in the company, valued at $11,659,422.84. This trade represents a 0.12 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.82 on Wednesday. The firm has a market capitalization of $24.40 million, a P/E ratio of -1.51 and a beta of 1.94. Retractable Technologies, Inc. has a 52 week low of $0.56 and a 52 week high of $1.34. The stock has a 50 day moving average price of $0.66 and a two-hundred day moving average price of $0.85. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Retractable Technologies in a research note on Monday. They issued a “hold” rating on the stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.